This inventor holds 1 USPTO granted patent. Top assignees: Mnh Bio Co., Ltd, Seoul National University. Active years: 2025.
Company Filing History:
1 out of 1 
1 out of 1,779 
Years Active: 2025
Title: Innovations of Yu-Jung Hwang in Hearing Loss Treatment
Introduction
Yu-Jung Hwang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical formulations, particularly in the treatment of hearing loss. His innovative approach combines advanced materials to create effective therapeutic solutions.
Latest Patents
Yu-Jung Hwang holds a patent for a controlled-release formulation aimed at treating hearing loss. The patent, titled "Controlled-release formulation for hearing loss and preparation method therefor," focuses on a method that disperses a steroidal anti-inflammatory agent encapsulated in low molecular weight hyaluronic acid within an aqueous solution of high molecular weight hyaluronic acid. This formulation is designed to enhance the delivery and effectiveness of the treatment for individuals suffering from hearing loss.
Career Highlights
Throughout his career, Yu-Jung Hwang has worked with prominent organizations, including Mnh Bio Co., Ltd and Seoul National University. His experience in these institutions has allowed him to develop and refine his innovative approaches to medical treatments.
Collaborations
Yu-Jung Hwang has collaborated with esteemed colleagues such as Dae-Jung Kang and Gwangmin An. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Yu-Jung Hwang's work in developing controlled-release formulations for hearing loss represents a significant advancement in medical innovation. His contributions are poised to make a meaningful impact on the treatment of hearing loss, showcasing the importance of research and collaboration in the field of medical science.